Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 1
2010 1
2011 2
2012 6
2013 5
2014 2
2015 5
2016 7
2017 4
2018 6
2019 13
2020 8
2021 14
2022 8
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
Pediatric IgG4-related disease: a descriptive review.
Hara S, Yoshida M, Sanada H, Suzuki Y, Sato Y, Mizushima I, Kawano M. Hara S, et al. Among authors: mizushima i. Expert Rev Clin Immunol. 2024 Jan-Jun;20(1):97-119. doi: 10.1080/1744666X.2023.2274358. Epub 2024 Jan 8. Expert Rev Clin Immunol. 2024. PMID: 37874048 Review.
Enrichment of type I interferon signaling in colonic group 2 innate lymphoid cells in experimental colitis.
Irie E, Ishihara R, Mizushima I, Hatai S, Hagihara Y, Takada Y, Tsunoda J, Iwata K, Matsubara Y, Yoshimatsu Y, Kiyohara H, Taniki N, Sujino T, Takabayashi K, Hosoe N, Ogata H, Teratani T, Nakamoto N, Mikami Y, Kanai T. Irie E, et al. Among authors: mizushima i. Front Immunol. 2022 Oct 4;13:982827. doi: 10.3389/fimmu.2022.982827. eCollection 2022. Front Immunol. 2022. PMID: 36268010 Free PMC article.
[IgG4-related kidney disease. Diagnosis and treatment].
Kawano M, Mizushima I, Yamada K, Taniguchi Y, Saeki T. Kawano M, et al. Among authors: mizushima i. Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(1):8-16. doi: 10.2177/jsci.38.8. Nihon Rinsho Meneki Gakkai Kaishi. 2015. PMID: 25765684 Free article. Review. Japanese.
83 results